Since the beginning of March, Hexoskin has been working with governments and health systems in the US, UK, and Canada to define actions to support healthcare services during the COVID-19 response.
We are currently putting in place patient monitoring programs in hospitals and at home for COVID-19 patients. These projects are important to support telehealth services, but also to gather data for medical research and manage the public response to the virus.
The data collected will also be used to develop AI/machine learning software to better assess the risk of COVID-19 patients recovering at home, and generate evidence that will guide future vaccination campaigns. Hexoskin biometric shirts can continuously measure respiration effort in addition to cardiac activity, which provides unique data to understand the evolution of the disease and its effects on lung function.
We are also working with health systems on rapidly setting up programs to ensure the continuity of care for patients currently enrolled in cardiac and pulmonary rehabilitation programs with online tools.
We understand that hospitals are currently focused 100% on hospitalized patients, that's why Hexoskin is setting up telehealth teams of its own and offering these resources to support these programs and complement health systems' resources.
If you are looking for help for telehealth programs or COVID-19 home monitoring programs please contact us today: firstname.lastname@example.org / 1-888-887-2044
Montreal-based @Hexoskin has created a high-tech shirt capable of monitoring #COVID19 patients from home. This #technology is helping to reduce the burden on healthcare facilities and workers as we fight COVID-19.— Invest in Canada (@invest_canada) June 18, 2020
Learn more: https://t.co/QbVXZ3KQVr#CanadaResilient pic.twitter.com/oQmWAJNChH
Health care of tomorrow, today: How artificial intelligence is fighting the current, and future, #COVID19 pandemic: https://t.co/AxwZbQNFCF ft @envisagenics @Hexoskin @AuransaInc @healx #ai #machinelearning #medtwitter via @thehill— Alliance for Artificial Intelligence in Healthcare (@theaaih) April 20, 2020
Don't let #COVID19 be in the way of your #clinicaltrials. Hexoskin can support your virtual clinical trials needs (logistics, phone/video support and follow-ups, equipment, etc.). email@example.com / 1-888-887-2044— Hexoskin - Sensors & AI (@Hexoskin) March 31, 2020
Félicitations à @hexoskin, qui reçoit le médaillon de reconnaissance, distinguant les projets sélectionnés lors de l'appel à solutions #COVID19. Pour relire le communiqué du @economie_quebec : https://t.co/bwtaEmhVCO pic.twitter.com/esvE6e4PHU— MEDTEQ+ (@MEDTEQ_CA) September 11, 2020